Xbrane Biopharma to host third-quarter interim report presentation

• Xbrane Biopharma will publish its January-September 2026 interim report on October 30 at 8 a.m. CET.
• An English-language presentation will follow on October 30 at 9 a.m. CET, with a Q&A session.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xbrane Biopharma AB published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.